IDH1 and central nervous system cancer: The patients with HOXB7 high expression, IDH1 wild-type and 1p/19q non-codeletion subgroups all had similar survival trends, which further illustrate the association between HOXB7 and IDH1 wild-type gliomas, as well as 1p/19q non-codeletion gliomas.